| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | NBIX Neurocrine Biosciences Inc | Rastetter William H48 | Director | Sell | 4,300 | $101.43 | $436,135.24 | -9.1% | -2.0% | +32.2% | |
| May 1, 2023 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 15,000 | $0.14 | $2,100.00 | +0.7% | - | - | |
| May 1, 2023 | MRK Merck & Co., Inc. | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 141,599 | $115.55 | $16,361,592.80 | -31.4% | -7.7% | +14.1% | |
| May 1, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $230.36 | $3,685,785.80 | -39.1% | +4.6% | +1.0% | |
| Apr 28, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 225,000 | $398.48 | $89,657,657.04 | - | +14.9% | +85.3% | |
| Apr 28, 2023 | MRK Merck & Co., Inc. | Davis Robert M46 | Chairman, CEO &President | Sell | 143,329 | $114.93 | $16,472,844.97 | -34.5% | -8.2% | +16.7% | |
| Apr 28, 2023 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Sell | 39,371 | $0.37 | $14,480.65 | -0.5% | - | - | |
| Apr 28, 2023 | MRMD Marimed Inc. | Levine Jon R | President And CEO | Sell | 49,393 | $0.38 | $18,611.28 | -0.2% | - | - | |
| Apr 27, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 5,005,000 | $0.01 | $25,210.00 | +2.6% | - | - | |
| Apr 27, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $226.25 | $3,620,078.03 | -37.6% | +6.6% | +2.7% | |
| Apr 26, 2023 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 10,000 | $0.38 | $3,837.85 | +0.5% | - | - | |
| Apr 26, 2023 | MRK Merck & Co., Inc. | Romanelli Joseph57 | President, Human Health Int?l | Buy | 409 | $108.40 | $44,336.21 | +0.3% | -4.6% | +18.4% | |
| Apr 25, 2023 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 100 | $103.82 | $10,382.00 | -0.4% | -2.3% | +35.8% | |
| Apr 25, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $227.34 | $3,637,458.20 | -43.8% | +8.6% | +4.7% | |
| Apr 24, 2023 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 14,400 | $103.48 | $1,490,058.72 | -35.1% | -3.4% | +35.3% | |
| Apr 24, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 15,000 | $0.04 | $600.00 | - | - | - | |
| Apr 21, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $226.86 | $3,629,783.76 | -37.3% | +5.9% | +3.1% | |
| Apr 21, 2023 | NBIX Neurocrine Biosciences Inc | Rastetter William H48 | Director | Sell | 6,937 | $105.03 | $728,605.23 | -8.6% | -6.0% | +26.7% | |
| Apr 20, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $223.96 | $1,343,754.52 | -5.1% | +7.6% | +5.7% | |
| Apr 19, 2023 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin48 | General Counsel | Sell | 1,290 | $1.27 | $1,640.88 | -1.5% | +19.8% | +42.7% | |
| Apr 19, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 115 | $1.28 | $146.97 | -0.2% | +19.8% | +42.7% | |
| Apr 19, 2023 | ESPR Esperion Therapeutics, Inc. | Foody Joanne M.73 | Chief Medical Officer | Sell | 938 | $1.27 | $1,192.20 | -0.7% | +19.8% | +42.7% | |
| Apr 19, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $226.45 | $3,623,258.79 | -57.3% | +5.0% | +4.5% | |
| Apr 18, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 4,338 | $175.94 | $763,227.72 | -14.1% | -2.1% | -12.9% | |
| Apr 18, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 9,709 | $0.04 | $388.74 | - | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.